Last updated: August 17, 2026

Application No. 19/347,608

TREATMENT METHODS

Final Rejection

Filed

Oct 01, 2025

Priority

Mar 14, 2020 — AU 2020900782 +2 more

Examiner

PECKHAM, RICHARD GRANT

Art Unit

1627

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Levon Michael Khachigian

OA Round

2 (Final)

Interview Optional

— +37.0% interview lift. Examiner has a relatively high allowance rate (67%); +37.0% interview lift. A written response may suffice.

Based on 131 resolved cases, 2023–2026

Examiner Intelligence

PECKHAM, RICHARD GRANT View full profile →

Grants 67% — above average

Career Allowance Rate

88 granted / 131 resolved

+7.2% vs TC avg

Strong +37% interview lift

Without

With

+37.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

68 currently pending

Career history

182

Total Applications

across all art units

Statute-Specific Performance

§101

3.2%

-36.8% vs TC avg

§103

29.1%

-10.9% vs TC avg

§102

16.4%

-23.6% vs TC avg

§112

29.5%

-10.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 131 resolved cases

Prosecution Timeline

Oct 01, 2025

Application Filed

Apr 29, 2026

Non-Final Rejection mailed

Jun 29, 2026

Response Filed

Jul 21, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/906,653

Patent 12703691

PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND THEIR USE

3y 10m to grant Granted Aug 11, 2026

18/164,044

Patent 12678451

CANNABINOID AND OMEGA FATTY ACID COMPOSITIONS AND METHODS OF USING

3y 5m to grant Granted Jul 14, 2026

17/298,460

Patent 12673022

DRUG DELIVERY SYSTEM USING SOLUTION

5y 1m to grant Granted Jul 07, 2026

17/442,733

Patent 12648936

ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF

4y 8m to grant Granted Jun 09, 2026

17/416,320

Patent 12642794

DOSE REGIMENS FOR USE OF LY3154207 IN THE TREATMENT OF DOPAMINERGIC CNS DISORDERS

4y 11m to grant Granted Jun 02, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

67%

Grant Probability

99%

With Interview (+37.0%)

3y 3m (~2y 4m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 131 resolved cases by this examiner. Grant probability derived from career allowance rate.